Does NEPAFENAC Cause Off label use? 43 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Off label use have been filed in association with NEPAFENAC (ILEVRO). This represents 2.4% of all adverse event reports for NEPAFENAC.
43
Reports of Off label use with NEPAFENAC
2.4%
of all NEPAFENAC reports
0
Deaths
5
Hospitalizations
How Dangerous Is Off label use From NEPAFENAC?
Of the 43 reports, 5 (11.6%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEPAFENAC. However, 43 reports have been filed with the FAERS database.
What Other Side Effects Does NEPAFENAC Cause?
Eye pain (393)
Drug ineffective (270)
Treatment failure (208)
Vision blurred (133)
Eye irritation (67)
Visual impairment (66)
Product quality issue (57)
Liquid product physical issue (55)
Cystoid macular oedema (42)
Ocular hyperaemia (42)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which NEPAFENAC Alternatives Have Lower Off label use Risk?
NEPAFENAC vs NERATINIB
NEPAFENAC vs NETARSUDIL
NEPAFENAC vs NETUPITANT\PALONOSETRON
NEPAFENAC vs NEULASTA
NEPAFENAC vs NEUPOGEN